Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. November 2024 17:45 ET | Quelle: DiagnaMed Holdings Corp.

DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on molecular hydrogen and AI...
21. August 2024 08:00 ET | Quelle: DiagnaMed Holdings Corp.

DiagnaMed Expands with Drug and Clinical Research AI Platform

Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development and discovering potential novel treatments for...
03. Juli 2024 16:00 ET | Quelle: DiagnaMed Holdings Corp.

DiagnaMed Cancels Previously Announced Private Placement

TORONTO, July 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI,...
13. Februar 2023 07:15 ET | Quelle: Diagnamed Holdings Corp.

DiagnaMed Announces Appointment of New Director

TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health generative AI company, announced today that Ms. Emily Davis resigned...
08. November 2022 07:45 ET | Quelle: Diagnamed Holdings Corp.

DiagnaMed Holdings Announces Listing on the Canadian Securities Exchange

Focusing on novel AI-based digital diagnostics and therapeutics solutions for brain health Developing BRAIN AGE™, an electroencephalogram-based (EEG) artificial intelligence solution to detect an...